<VariationArchive RecordType="classified" VariationID="1810382" VariationName="NM_000277.3(PAH):c.1176dup (p.Asn393Ter)" VariationType="Duplication" Accession="VCV001810382" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-01-21" DateCreated="2023-01-15" MostRecentSubmission="2023-01-15">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1867395" VariationID="1810382">
      <GeneList>
        <Gene Symbol="PAH" FullName="phenylalanine hydroxylase" GeneID="5053" HGNC_ID="HGNC:8582" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>12q23.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="102836889" stop="102958441" display_start="102836889" display_stop="102958441" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="103232103" stop="103311380" display_start="103232103" display_stop="103311380" Strand="-" />
          </Location>
          <OMIM>612349</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000277.3(PAH):c.1176dup (p.Asn393Ter)</Name>
      <CanonicalSPDI>NC_000012.12:102843668:AAAA:AAAAA</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>12q23.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="12" Accession="NC_000012.12" start="102843668" stop="102843669" display_start="102843668" display_stop="102843669" variantLength="1" positionVCF="102843668" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="12" Accession="NC_000012.11" start="103237446" stop="103237447" display_start="103237446" display_stop="103237447" variantLength="1" positionVCF="103237446" referenceAlleleVCF="T" alternateAlleleVCF="TA" />
      </Location>
      <OtherNameList>
        <Name>NM_001354304.2:c.1176dup</Name>
      </OtherNameList>
      <ProteinChange>N393*</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.11" sequenceAccession="NC_000012" sequenceVersion="11" change="g.103237450dup" Assembly="GRCh37">
            <Expression>NC_000012.11:g.103237450dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000012.12" sequenceAccession="NC_000012" sequenceVersion="12" change="g.102843672dup" Assembly="GRCh38">
            <Expression>NC_000012.12:g.102843672dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008690.2" sequenceAccession="NG_008690" sequenceVersion="2" change="g.119742dup">
            <Expression>NG_008690.2:g.119742dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000277.3" sequenceAccession="NM_000277" sequenceVersion="3" change="c.1176dup" MANESelect="true">
            <Expression>NM_000277.3:c.1176dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000268.1" sequenceAccession="NP_000268" sequenceVersion="1" change="p.Asn393Ter">
            <Expression>NP_000268.1:p.Asn393Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001354304.2" sequenceAccession="NM_001354304" sequenceVersion="2" change="c.1176dup">
            <Expression>NM_001354304.2:c.1176dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001341233.1" sequenceAccession="NP_001341233" sequenceVersion="1" change="p.Asn393Ter">
            <Expression>NP_001341233.1:p.Asn393Ter</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001587" Type="nonsense" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000277.3(PAH):c.1176dup (p.Asn393Ter) AND Phenylketonuria" Accession="RCV002509869" Version="1">
        <ClassifiedConditionList TraitSetID="159">
          <ClassifiedCondition DB="MedGen" ID="C0031485">Phenylketonuria</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>reviewed by expert panel</ReviewStatus>
            <Description DateLastEvaluated="2022-07-30" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-07-30" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-01-15" MostRecentSubmission="2023-01-15">
        <ReviewStatus>reviewed by expert panel</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/fd3c60ab-667c-460a-a5f3-592256fb7342</URL>
        </Citation>
        <ConditionList>
          <TraitSet ID="159" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3795" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Phenylketonurias</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Phenylketonuria</ElementValue>
                <XRef ID="Phenylketonuria/5714" DB="Genetic Alliance" />
                <XRef ID="MONDO:0009861" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Oligophrenia phenylpyruvica</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Folling disease</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PKU</ElementValue>
                <XRef Type="MIM" ID="261600" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000507953" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000522527" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529111" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000560957" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592287" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000260641" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000330994" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505124" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000506557" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000596351" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000505064" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000591289" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000529346" DB="Genetic Testing Registry (GTR)" />
                <XRef ID="GTR000592289" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Phenylalanine hydroxylase (PAH) deficiency results in intolerance to the dietary intake of the essential amino acid phenylalanine and produces a spectrum of disorders. The risk of adverse outcome varies based on the degree of PAH deficiency. Without effective therapy, most individuals with severe PAH deficiency, known as classic PKU, develop profound and irreversible intellectual disability. Affected individuals on an unrestricted diet who have phenylalanine levels above normal but below 1,200 Âµmol/L (20 mg/dL) are at much lower risk for impaired cognitive development in the absence of treatment.</Attribute>
                <XRef ID="NBK1504" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301677</ID>
                <ID Source="BookShelf">NBK1504</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="USPSTF, 2008">
                <ID Source="pmc">2267416</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2011">
                <ID Source="PubMed">21915151</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="ACMG, 2014">
                <ID Source="PubMed">24385074</ID>
              </Citation>
              <Citation Type="Recommendation" Abbrev="ACMG, 2014">
                <ID Source="pmc">3918542</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="Camp et al., 2014">
                <ID Source="PubMed">24667081</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="GMDI/SERN, 2022">
                <URL>https://managementguidelines.net/guidelines.php/136/PKU%20Nutrition%20Guidelines/Version%202.5</URL>
                <CitationText>PKU Nutrition Management Guidelines</CitationText>
              </Citation>
              <Citation Type="Position Statement" Abbrev="HGS Australasia, 2019">
                <URL>https://www.hgsa.org.au/documents/item/8694</URL>
                <CitationText>Policy: Recommendations for Screening for Specific Disorders</CitationText>
              </Citation>
              <XRef ID="716" DB="Orphanet" />
              <XRef ID="C0031485" DB="MedGen" />
              <XRef ID="MONDO:0009861" DB="MONDO" />
              <XRef Type="MIM" ID="261600" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion FDARecognizedDatabase="true" ID="5503551" SubmissionDate="2022-12-22" DateLastUpdated="2023-01-15" DateCreated="2023-01-15">
        <ClinVarSubmissionID localKey="fd3c60ab-667c-460a-a5f3-592256fb7342" localKeyIsSubmitted="1" submittedAssembly="GRCh38" />
        <ClinVarAccession Accession="SCV002818504" DateUpdated="2023-01-15" DateCreated="2023-01-15" Type="SCV" Version="1" SubmitterName="ClinGen PAH Variant Curation Expert Panel" OrgID="506558" OrganizationCategory="consortium" OrgAbbreviation="PAH_EP" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-07-30">
          <ReviewStatus>reviewed by expert panel</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <URL>https://erepo.clinicalgenome.org/evrepo/ui/interpretation/fd3c60ab-667c-460a-a5f3-592256fb7342</URL>
          </Citation>
          <Comment>The nonsense variant c.1176dup (p.Asn393Ter) occurs in exon 11 and is predicted to result in NMD. The variant is absent from population databases. At least one classical PKU patient has been reported (PMID: 20188615) homozygous for this variant. In summary, this variant meets criteria to be classified as Pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PVS1, PM2, PM3_supporting, PP4.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ClinGen PAH ACMG Specifications v1</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/blqqhvgi/clingen_pah_acmg_specifications_v1.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>curation</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PAH" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>NM_001354304.2:c.1176dup</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000012.12:g.102843672dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MONDO" ID="MONDO:0009861" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12473607</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5503551" TraitType="Disease" MappingType="XRef" MappingValue="MONDO:0009861" MappingRef="MONDO">
        <MedGen CUI="C0031485" Name="Phenylketonuria" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

